Sources: FDA Drug Safety Communication, Jan 13, 2026 FDA prescribing labels: Ozempic, Wegovy, Mounjaro, Zepbound EMA / PRAC statement on NAION, June 6, 2025 UK MHRA Drug Safety Update on semaglutide & NAION Endocrine Society of India Clinical Practice Guidelines for Obesity, 2025 Disclaimer: This content is for educational purposes only and is not medical advice, diagnosis, or treatment
Their success depends on the quality of supervision and support
Citing data from Purple Lab/Lexus Nexus, Axios recently created a map of the places across the U.S
PCR fragments were purified with the QIAquick PCR purification kit from Qiagen
We show readers that GLP-1RAs have also been found to significantly reduce the risks of heart failure, atherosclerosis (AS), and hypertension, highlighting their broad therapeutic potential
Read it here: To view or add a comment, sign in 1,595 followers